Skip to main content
padlock icon - secure page this page is secure

Open Access Thematic Platform in vitro Diagnostics Technological Progress with a Powerful Network

Download Article:
 Download
(PDF 274.8 kb)
 
In vitro diagnostics (IVD) has huge potential. Primary drivers in the global market are the patient's awareness of infectious diseases, the introduction of advanced molecular and tissue diagnostic tests for patient-stratified and targeted anti-cancer therapy and, last but not least, the growing geriatric population. Rapid progress in device miniaturization and information technology (IT) offers new possibilities in decentralized testing. Grand View Research Inc. expects the global market for IVD to reach US $ 74.3 billion by 2020. Hence the launch in 2015 by the NTN Swiss Biotech – together with the driving forces of Biotechnet Switzerland – of the 'Thematic Platform in vitro Diagnostics'.

1 Reference.

No Supplementary Data.
No Article Media
No Metrics

Keywords: BIOSENSORS; COMPANION DIAGNOSTICS; IN VITRO DIAGNOSTICS; PERSONALIZED MEDICINE; POINT-OF-CARE (POC) TESTING; PRECISION MEDICINE; THERAPEUTIC DRUG MONITORING (TDM)

Document Type: Regular Paper

Affiliations: Science and technology journalist

Publication date: 01 September 2016

More about this publication?
  • International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions

    CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more